| Execution period | 5 years |
|---|
BSE filing, NSE: NILE. Summary written from the filing by ALFA Finder's alert engine.
Nile Ltd: key numbers
- Share price
- ₹1,339.65
- Market cap
- ₹402.1 Cr
- Revenue (annual)
- ₹1,041 Cr
- Net profit (annual)
- ₹55.26 Cr
- P/E (TTM)
- 6.3×Sector 16.9×
- Promoter holding
- 50.39%+0.00% QoQ
- FII holding
- 0.16%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nile Ltd
All →Nile Management Change
Nile Limited announced the re-appointment of Mr. Sandeep Vuyyuru Ramesh as Executive Director for 36 months. M/s M. Bhaskara Rao & Co was also appointed as Statutory Auditor.
- Execution
- 36 months
Nile Annual General Meeting
Nile Limited submitted the proceedings of its 42nd Annual General Meeting held on September 30, 2026. Shareholders approved the adoption of financial statements and the re-appointment of directors.
Nile Annual General Meeting
Nile Limited has scheduled its 42nd Annual General Meeting for September 30, 2026. The company also released its 42nd Annual Report for the 2025-26 fiscal year.
Nile Other Announcement
Nile Limited reported nil requests for physical share transfers during August 2026. The filing complies with the SEBI special window for re-lodgment of transfer requests.
Nile Management Change
Nile Limited re-appointed Sandeep Vuyyuru Ramesh as Executive Director for 36 months. The company also appointed G Madhavaiah as Cost Auditor for 12 months.
Nile Q1 FY27 Results: Net Profit ₹8.1 Cr, Down 45.6% YoY
Nile Ltd reported revenue from operations of ₹280.7 Cr (+14.4% YoY) and net profit of ₹8.1 Cr (-45.6% YoY) for Q1 FY27.
- Key figure
- Net profit ₹8.1 Cr · -45.6% YoY
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.